Rajiv Khanna is the founding Coordinator of QIMR Berghofer Centre for Immunotherapy and Vaccine Development. He is currently appointed as Senior Scientist at QIMR Berghofer and is also appointed as Honorary Professor at the University of Queensland and Griffith University, Brisbane, Australia. Prof.
Khanna is a Fellow of Australian Academy of Health and Medical Sciences and was awarded Order of Australia in 2017. He has extensive expertise in immunotherapy clinical trials, cancer immunology and vaccine development. Prof. Khanna has been appointed as a consultant to Atara Biotherapeutics (US), Cellevolve (US), CSL Ltd, Cellestis Ltd and Oxford Immunotech (UK).